ABIRTEGA
Live / Applied — First extension granted (statement of use) (as of 18 Jun 2025)
What this means for you
Not registered yet, but its 26 Mar 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98469040
- Mark type
- Stylized text
- Filed
- 26 Mar 2024
- Published for opposition
- 10 Dec 2024
- Attorney of record
- Joshua G. Gigger
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for use in oncology; pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of prostate cancer; androgen biosynthesis inhibitors in the nature of pharmaceutical preparations for use in oncology; androgen biosynthesis inhibitors in the nature of pharmaceutical preparations for the treatment of cancer; androgen biosynthesis inhibitors in the nature of pharmaceutical preparations for the treatment of prostate cancer; pharmaceutical products affecting hormone levels for medical purposes, specifically for the treatment of cancer
Owner
- CivicaScript, LLC, Lehi, UT, US
- CivicaScript, LLC, Lehi, UT, US
Prosecution history
- 05 Jan 2026 — TEAS STATEMENT OF USE RECEIVED
- 19 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jun 2025 — SOU EXTENSION 1 GRANTED
- 18 Jun 2025 — SOU EXTENSION 1 FILED
- 18 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Dec 2024 — PUBLISHED FOR OPPOSITION
- 04 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Nov 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 Nov 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 13 Nov 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 07 Oct 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 07 Oct 2024 — NON-FINAL ACTION E-MAILED